ImmunologybioRxiv
Unraveling the Power of NAP-CNB's Machine Learning-enhanced Tumor Neoantigen Prediction
A. Mendez-Perez, A. M. Acosta-Moreno, C. Wert-Carvajal…·E. Veiga
This study validates a machine learning platform, NAP-CNB, for identifying tumor neoantigens using RNAseq data, showing improved antitumor responses with multiantigen vaccination.
DOI 10.7554/elife.95010